American International Group, Inc. Icosavax, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$5.95 - $15.79 $333 - $884	-56 Reduced 0.41%	13,690 $215,000
Q3 2023 Nov 13, 2023	BUY	$7.22 - $10.05 $3,530 - $4,914	489 Added 3.69%	13,746 $106,000
Q2 2023 Aug 04, 2023	BUY	$4.89 - $10.57 $12,366 - $26,731	2,529 Added 23.57%	13,257 $131,000
Q1 2023 May 12, 2023	BUY	$5.62 - $11.51 $1,202 - $2,463	214 Added 2.04%	10,728 $62,000
Q4 2022 Feb 10, 2023	SELL	$2.32 - $10.97 $90 - $427	-39 Reduced 0.37%	10,514 $83,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $463 - $1,381	150 Added 1.44%	10,553 $33,000
Q2 2022 Aug 12, 2022	SELL	$5.7 - $10.33 $9,131 - $16,548	-1,602 Reduced 13.34%	10,403 $60,000
Q1 2022 May 13, 2022	BUY	$4.41 - $22.5 $21,591 - $110,160	4,896 Added 68.87%	12,005 $85,000
Q4 2021 Feb 11, 2022	SELL	$21.07 - $34.98 $4,487 - $7,450	-213 Reduced 2.91%	7,109 $163,000
Q3 2021 Nov 12, 2021	BUY	$24.85 - $40.25 $181,951 - $294,710	7,322 New	7,322 $217,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.